Top Suppliers:I want be here
  • BioBioPha
  • China
  • Product Name: Ailanthone
  • Price: ￥1750.0/5mg
  • Purity: 98.0%
  • Stocking Period: 10 Day
  • Contact: Xueping-Zheng
Related CAS#:
1158522-08-7 1254118-26-7
940364-43-2 134104-43-1
131615-57-1 6906-52-1
930439-75-1 1018584-77-4
1375289-11-4 1415821-77-0

981-15-7

981-15-7 structure
981-15-7 structure
  • Name: Ailanthone
  • Chemical Name: ailanthone
  • CAS Number: 981-15-7
  • Molecular Formula: C20H24O7
  • Molecular Weight: 376.400
  • Catalog: Natural product Moss
  • Create Date: 2018-03-22 08:00:00
  • Modify Date: 2024-01-04 13:39:25
  • Ailanthone (Δ13-Dehydrochaparrinone) is a potent inhibitor of both full-length androgen receptor (AR) (IC50=69 nM) and constitutively active truncated AR splice variants (AR1-651 IC50=309 nM).
Name ailanthone
Synonyms Picrasa-3,13(21)-diene-2,16-dione, 11,20-epoxy-1,11,12-trihydroxy-, (1β,11β,12α)-
13,21-Didehydrochaparrinone
Ailanthone
Picrasa-3,13(21)-diene-2,16-dione, 11,20-epoxy-1,11,12-trihydroxy-, (1β,11β,12α,14ξ)-
(1β,11β,12α,14ξ)-1,11,12-Trihydroxy-11,20-epoxypicrasa-3,13(21)-diene-2,16-dione
(1β,11β,12α)-1,11,12-Trihydroxy-11,20-epoxypicrasa-3,13(21)-diene-2,16-dione
Description Ailanthone (Δ13-Dehydrochaparrinone) is a potent inhibitor of both full-length androgen receptor (AR) (IC50=69 nM) and constitutively active truncated AR splice variants (AR1-651 IC50=309 nM).
Related Catalog
Target

IC50: 69 nM (Full-length androgen receptor), 309 nM (AR1-651)[1]

In Vitro Ailanthone is a potent inhibitor of both full-length AR (AR-FL) and constitutively active truncated AR splice variants (AR-Vs). Ailanthone binds to the co-chaperone protein p23 and prevents AR's interaction with HSP90, thus resulting in the disruption of the AR-chaperone complex followed by ubiquitin/proteasome-mediated degradation of AR as well as other p23 clients including AKT and Cdk4, and downregulates AR and its target genes in PCa cell lines and orthotopic animal tumours. In addition, Ailanthone blocks tumour growth and metastasis of CRPC[1]. Ailanthone has been shown to possess an growth-inhibitory effect against several cancer cell lines including HepG2, Hep3B, R-HepG2, Jurkat, HeLa, MCF-7, MDA-MB-231 and A549 cells. Ailanthone inhibits Huh7 cell growth through the induction of mitochondrion-mediated cell apoptosis and G0/G1 cell cycle arrest. Ailanthone-induced apoptosis is mitochondrion-mediated and involved the PI3K/AKT signaling pathway in Huh7 cells[2].
In Vivo Not only i.p. administration but also p.o. administration of Ailanthone has excellent efficiency for blocking the growth of CRPC xenografts. In pharmacokinetic studies, Ailanthone exhibits good solubility in water and good bioavailability (>20%). In addition, Ailanthone effectively suppresses CRPC tumour growth, despite not reaching a steady state of plasma drug concentration during the course of treatment[1].
Cell Assay For SRB assay, cells are cultured in complete RPMI 1640 and incubated with indicated concentrations of Ailanthone or cells are maintained in fresh phenol red-free RPMI 1640 medium with 5% charcoal-stripped FBS, 1 nM DHT and indicated compounds. After 48 or 72 h, the cells are then fixed and the cell growth is detected with the SRB assay. For colony formation assay, prostate cancer cells are incubated with indicated concentrations of Ailanthone in complete RPMI 1640 for 2 weeks and then cells are fixed with 4% paraformaldehyde and stained with crystal violet. Colonies are visualized under a microscope, and all of the fields are imaged and counted. Colony formation as a percentage of vehicle control for each cell line is presented[1].
Animal Admin Mice[1] In orthotopic castration-resistant prostate cancer xenografts model, mice are intraperitoneally injected with Ailanthone (2 mg/kg), MDV (10 mg/kg) or DMSO (as controls). Prostate tumour growth and local metastasis are monitored weekly using the IVIS Imaging System. Images and measurements of bioluminescent signals are acquired and analysed using Living Image and Xenogen software[1].
References

[1]. He Y, et al. Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer. Nat Commun. 2016 Dec 13;7:13122.

[2]. Zhuo Z, et al. Ailanthone Inhibits Huh7 Cancer Cell Growth via Cell Cycle Arrest and Apoptosis In Vitro and In Vivo. Sci Rep. 2015 Nov 3;5:16185.
Density 1.5±0.1 g/cm3
Boiling Point 641.0±55.0 °C at 760 mmHg
Molecular Formula C20H24O7
Molecular Weight 376.400
Flash Point 231.6±25.0 °C
Exact Mass 376.152191
PSA 113.29000
LogP -0.76
Vapour Pressure 0.0±4.3 mmHg at 25°C
Index of Refraction 1.640
Storage condition 2-8C

CHEMICAL IDENTIFICATION

RTECS NUMBER :
KT0930000
CHEMICAL NAME :
2H-1,11c-(Epoxymethano)phenanthro(10,1-bc)pyran-5,10( 3H,6ah)-dione, 1,3a,4,7,7a,11,11a,11b- octahydro-8,11a-beta-dimethyl-3-methylene-1-alpha,2-b eta,11-beta-trihydrox y-
CAS REGISTRY NUMBER :
981-15-7
LAST UPDATED :
199303
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C20-H24-O7
MOLECULAR WEIGHT :
376.44

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
9800 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PSSGAR Parassitologia. (Parassitologia, E. Biocca, A. Corradetta, Leonardo, via Baglivi 5, 00161 Roma, Italy) V.1- 1959- Volume(issue)/page/year: 10,215,1968
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
31400 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
EJMCA5 European Journal of Medicinal Chemistry--Chimie Therapeutique. (Editions Scientifiques Elsevier, 29 rue Buffon, F-75005, Paris, France) V.9- 1974- Volume(issue)/page/year: 26,345,1991
Precursor  1

DownStream  0


Chemsrc provides CAS#:981-15-7 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 981-15-7 | Chemsrc address: https://www.chemsrc.com/en/baike/895765.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved